These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30594862)

  • 1. Multi-Component Mechanism of H2 Relaxin Binding to RXFP1 through NanoBRET Kinetic Analysis.
    Hoare BL; Bruell S; Sethi A; Gooley PR; Lew MJ; Hossain MA; Inoue A; Scott DJ; Bathgate RAD
    iScience; 2019 Jan; 11():93-113. PubMed ID: 30594862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1.
    Sethi A; Bruell S; Patil N; Hossain MA; Scott DJ; Petrie EJ; Bathgate RAD; Gooley PR
    Nat Commun; 2016 Apr; 7():11344. PubMed ID: 27088579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric RXFP1 and RXFP2 Receptors Highlight the Similar Mechanism of Activation Utilizing Their N-Terminal Low-Density Lipoprotein Class A Modules.
    Bruell S; Kong RC; Petrie EJ; Hoare B; Wade JD; Scott DJ; Gooley PR; Bathgate RA
    Front Endocrinol (Lausanne); 2013; 4():171. PubMed ID: 24273532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2.
    Sethi A; Bruell S; Ryan T; Yan F; Tanipour MH; Mok YF; Draper-Joyce C; Khandokar Y; Metcalfe RD; Griffin MDW; Scott DJ; Hossain MA; Petrie EJ; Bathgate RAD; Gooley PR
    J Mol Biol; 2021 Oct; 433(21):167217. PubMed ID: 34454945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
    Scott DJ; Rosengren KJ; Bathgate RA
    Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin.
    Bruell S; Sethi A; Smith N; Scott DJ; Hossain MA; Wu QP; Guo ZY; Petrie EJ; Gooley PR; Bathgate RAD
    Sci Rep; 2017 Jun; 7(1):3294. PubMed ID: 28607406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation.
    Hopkins EJ; Layfield S; Ferraro T; Bathgate RA; Gooley PR
    J Biol Chem; 2007 Feb; 282(6):4172-84. PubMed ID: 17148455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.
    Kong RC; Petrie EJ; Mohanty B; Ling J; Lee JC; Gooley PR; Bathgate RA
    J Biol Chem; 2013 Sep; 288(39):28138-51. PubMed ID: 23926099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric relaxin peptides highlight the role of the A-chain in the function of H2 relaxin.
    Hossain MA; Wade JD; Bathgate RA
    Peptides; 2012 May; 35(1):102-6. PubMed ID: 22414484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1).
    Diepenhorst NA; Petrie EJ; Chen CZ; Wang A; Hossain MA; Bathgate RA; Gooley PR
    J Biol Chem; 2014 Dec; 289(50):34938-52. PubMed ID: 25352603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping key regions of the RXFP2 low-density lipoprotein class-A module that are involved in signal activation.
    Kong RC; Bathgate RA; Bruell S; Wade JD; Gooley PR; Petrie EJ
    Biochemistry; 2014 Jul; 53(28):4537-48. PubMed ID: 24983702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin.
    Chan LJ; Rosengren KJ; Layfield SL; Bathgate RA; Separovic F; Samuel CS; Hossain MA; Wade JD
    J Biol Chem; 2012 Nov; 287(49):41152-64. PubMed ID: 23024363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the novel HiBiT tag to label cell surface relaxin receptors for BRET proximity analysis.
    Hoare BL; Kocan M; Bruell S; Scott DJ; Bathgate RAD
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00513. PubMed ID: 31384473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of fluorescent analogs of relaxin family peptides and their preliminary in vitro and in vivo characterization.
    Chan LJ; Smith CM; Chua BE; Lin F; Bathgate RA; Separovic F; Gundlach AL; Hossain MA; Wade JD
    Front Chem; 2013; 1():30. PubMed ID: 24790958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
    Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies.
    Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY
    Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.
    Hossain MA; Samuel CS; Binder C; Hewitson TD; Tregear GW; Wade JD; Bathgate RA
    Amino Acids; 2010 Jul; 39(2):409-16. PubMed ID: 20043231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290.
    Huang Z; Myhr C; Bathgate RA; Ho BA; Bueno A; Hu X; Xiao J; Southall N; Barnaeva E; Agoulnik IU; Marugan JJ; Ferrer M; Agoulnik AI
    Front Endocrinol (Lausanne); 2015; 6():128. PubMed ID: 26347712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relaxin receptor RXFP1 signals through a mechanism of autoinhibition.
    Erlandson SC; Rawson S; Osei-Owusu J; Brock KP; Liu X; Paulo JA; Mintseris J; Gygi SP; Marks DS; Cong X; Kruse AC
    Nat Chem Biol; 2023 Aug; 19(8):1013-1021. PubMed ID: 37081311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1.
    Hossain MA; Praveen P; Noorzi NA; Wu H; Harrison IP; Handley T; Selemidis S; Samuel CS; Bathgate RAD
    ACS Pharmacol Transl Sci; 2023 May; 6(5):842-853. PubMed ID: 37200817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.